To learn more about recent and upcoming presentations, please contact csdd@tufts.edu.

 

Upcoming Presentations

Examining the Vendor Qualification and Selection Process

Ken Getz

CORE East

Live | October 4-6

 

Overcoming Barriers Slowing the Adoption of Disruptive Technologies

Maria Florez

Disruptive Technologies in Clinical Trials

Boston, MA | October 10

 

Adopting Technologies that Enable Digital Transformations

Maria Florez

Precision in Clinical Trials Summit

San Diego, CA | October 16

 

Envisioning the Future Landscape: Preparing the Future Workforce for Drug Research & Development - A Workshop

Mary Jo Lamberti

National Academies

Washington D.C. | October 16-17

 

Clinical Trial Disruptions During Disasters and Public Health Emergencies

Ken Getz

CTTI and FDA public meeting

Virtual | October 18 - 19

 

Benchmarking Patient Enrollment and Use of Patient Recruitment Tactics

Mary Jo Lamberti, PhD

Outsourcing in Clinical Trials New England

Boston, MA | November 1

 

Optimizing Clinical Trial Performance

Ken Getz, MBA

OCT New England

Live | November 2

 

Assessing the Net Financial Benefits of Employing Digital Endpoint in Clinical Trials

Joseph DiMasi, PhD

4th Annual Digital Biomarkers & Digital Measurements East Summit

Boston, MA | November 2

 

Measuring Patient and Site Burden in Clinical Trials

Ken Getz, MBA

DIA Annual Meeting Japan

Live | November 5 - 8

 

Diversity and Representation in Oncology Trials

Zachary Smith, MA

Cancer Immunotherapy Summit

Boston, MA | Nov 6 - 8

 

Leveraging Patient Engagement Strategies to Optimize Protocol Performance

Ken Getz

Evolution Summit

Live | December 4

September 2023

Patient Preferences for Virtual and Remote Clinical Trial Services

Ken Getz, MBA

DPharm

Live | September 22

 

Increasing R&D Productivity to Sustain Biomedical Innovation

Ken Getz

IQVIA Institute Life Sciences Innovation Forum

Virtual | September 26

August 2023

How Lack of Inclusion Can Impact Women In STEM

Jennifer Kim, PhD

Cornell School of Medicine

Live | August 31st

 

Methods in Organizational Change Research: Dialogue on the Past, Present, and Future of Organization

Jennifer Kim, PhD

Academy of Management

Boston, MA | August 

 

Silence is Not Always Golden: Impact of Leader Intervention Against COVID-19 Microaggressions

Jennifer Kim, PhD

Academy of Management

Boston, MA | August 

 

July 2023

A Site Perspective: The Impact of the Last 5 Years

Abigail Dirks, MS

Clinical Operations in Oncology Trials East Coast

Boston, MA | July 11

June 2023

Performance, Interrupted: Examining DEI Dynamics That can Impact Team Performance in Drug Development

Jennifer Kim, PhD

DIA Annual Meeting

Boston, MA | June 26 - 29

 

Measuring Impact of Patient Engagement Across Research and Development

Jennifer Kim, PhD

DIA Annual Meeting

Boston, MA | June 26 - 29

 

Sponsor-CRO Collaborations and the Impact of Decentralized Clinical Trials

Mary Jo Lamberti, PhD

DIA Annual Meeting

Boston, MA | June 26

 

Maximizing Diversity in Clinical Trials

Ken Getz, MBA

Finn Partners

Boston, MA | June 20

 

The Impact of Patient Engagement on Drug Development Performance

Ken Getz, MBA

DIA China

Virtual | June 17

 

The Impact of the Last 5 Years on Investigative Sites

Abigail Dirks, MS and Ken Getz, MBA

ACRP

Virtual | June 14

 

Clinical Trials for Small Biotechs

Ken Getz, MBA

STAT News

Virtual | June 12

May 2023

Innovation in Clinical Research: Why it Takes So Long to Adopt a New Solution

Ken Getz, MBA

MAGI East Conference

Philadelphia, PA | May 21 - 24

 

Innovation in the Pharmaceutical Industry: New Estimates of R&D Costs

Joseph DiMasi

PhRMA R&D Roundtable

Boston, MA | May 11

 

Managing Protocol Complexity to Optimize Clinical Trial Performance

Ken Getz, MBA

Linking Leaders

Boston, MA | May 10

April 2023

The Economics of Implementing Phase 0 Techniques - Methods for Measuring Financial Value

Joseph DiMasi, PhD

4th International Phase-0/Microdosing Stakeholder Meeting: Intra-Target Microdosing (ITM): Revolutionizing Clinical Pharmacology and Drug Development

Boston, MA | April 24

 

The Impact of DCT Use of Sponsor-CRO Relationships

 Mary Jo Lamberti, PhD

Informa Decentralized Clinical Trials

Boston, MA | April 19

 

Quantifying the Value Proposition of DCT Deployment

Ken Getz, MBA

Informa Decentralized Clinical Trials

Boston, MA | April 18 - 20 

 

State of the Drug Development Industry

Ken Getz, MBA

Chief Medical Officers Summit

Boston, MA | April 3 - 4

 

 

 

March 2023

Assessing Patient Engagement Capabilities and Their Impact

Ken Getz, MBA

DIA Europe

Basel, Switzerland | March 23

 

Examining Current Patient Engagement Activities and Investment Within Sponsor and CRO Companies

Ken Getz, MBA

DIA Europe

Basel, Switzerland | March 22

 

 

February 2023

The Impact of Decentralized and Hybrid Trials on Sponsor-CRO Collaborations

 Mary Jo Lamberti, PhD

SCOPE Summit

Orlando, FL | December 8

 

Panel Discussion- Navigating Global Crises: Pandemic War, Hyperinflation and Supply Chain

Ken Getz, MBA

SCOPE Summit

Orlando, FL | February 7

 

 

January 2023

Remote Teams in Clinical Research During the COVID-19 Pandemic

Maria Florez, MA and Mary Jo Lamberti, PhD

Clinical Research Webinar

Virtual | January 26-27

 

Clinical Operations and Clinical Outsourcing Roundtables

Ken Getz, MBA

Linking Leaders

New York, NY | January 17-18

December 2022

New Insights into Managing Investigative Sites to Optimize Patient Enrollment Diversity

Ken Getz, MBA

Evolution Summit

Orlando, FL | December 8

 

Clinical Research Professionals and the Shift to Remote Work During the COVID-19 Pandemic

Maria Florez, MA and Mary Jo Lamberti, PhD

Clinical Operations in Oncology, Virtual Conference

Virtual | December 1

November 2022

Measuring the Impact of the Pandemic on Drug Development Productivity and Performance

Ken Getz, MBA

Outsourcing Clinical Trials New England

Boston, MA | November 10

 

New Trends and Practices Impacting the Drug Development Landscape

Ken Getz, MBA

CT Europe

Live | November 7-9

 

Increasing Efficiency and Reducing Cycle-Times in Drug Development: Multi-Stakeholder Views on the Topic

Zachary Smith, MA

Clinical Trials Europe

Virtual | November 3

 

Where Has the Industry Been and Where Should it Be Going?

Joseph DiMasi, PhD

Speid & Associates Inc. and Brown University Medical School

Virtual | November 2-4

 

Impact of Running Clinical Trials During the Pandemic and Lessons Learnt

Ken Getz, MBA and Maria Florez, MA

Clinical Trials Europe

Virtual | November 2-4

 

Digital Transformation and Clinical Research Team Effectiveness

Maria Florez, MA

Clinical Trials Europe

Virtual | November 2-4

 

Optimizing Protocol Design to Improve Performance and Efficiency

Ken Getz, MBA

Clinical Trials Europe

Virtual | November 2

 

October 2022

Digitizing Clinical Trials

Maria Florez, MA

18th Clinical Trials Innovation Programme

Boston, MA | October 26-27

 

The Economics of Decentralized Clinical Trials: Assessing the Net Financial Benefit

Joseph DiMasi, PhD

Decentralized Clinical Trials Summit

Philadelphia, PA | October 26

 

Accommodating and Managing Agile Drug Development Execution

Ken Getz, MBA

Chief Medical Officers Summit

Virtual | October 14

 

Exploring the Impact of Decentralized Clinical Trials

Ken Getz, MBA

Prometrika

Live & Virtual | October 13

 

The Impact of Decentralized Trials on Sponsor-CRO Collaborations

Mary Jo Lamberti, PhD

Outsourcing in Clinical Trials New England

Boston, MA | October 12-13

 

Impact of COVID-19 on Clinical Operations

Ken Getz, MBA

Dutch Federation of Pharmaceutical Medicine

Virtual | October 7

 

Diversity and Representation Among the Clinical Research Workforce: A factor in patient engagement and recruitment?

Maria Florez, MA

Scope Europe

Barcelona | October 3-4

 

Characterizing the Innovation Adoption Cycle for Innovations Supporting Virtual Clinical Trials

Maria Florez, MA

Scope Europe

Barcelona | October 3-4

 

September 2022

 
How We Become Agile to Remain Viable in a Post-COVID World

Ken Getz, MBA

DPharm

Virtual | September 29

 

Innovation Adoption Cycles for Tools Supporting DCT Research

Maria Florez, MA

Precision in Clinical Trials Summit

Frankfurt | September 28

 

Racial and Ethnic Disparities in Access to Professional Opportunities in Drug Development

Emily Botto, BA

Clinical Trials Global

Virtual | September 28

 

Accelerating Innovation Adoptions Supporting Clinical Trial Execution

Ken Getz, MBA

CTTI Fall Steering Committee Meeting

Washington D.C. | September 20

 

CRO Landscape Trends - Sponsor Demand, Sector Growth, and the Impact of COVID-19

Emily Botto, BA

Contract Pharma

New Brunswick, NJ | September 20

 

Evolving the Biomedical Innovation System

Ken Getz, MBA

IQVIA Life Sciences Innovation Forum

Virtual | September 13

 

The Changing Environment for RBQM

Ken Getz, MBA

RBQM Live

Virtual | September 8